Trial · NCT02284516
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Instillation site irritation | General disorders | Placebo | 11 | 354 | 12 |
| other | Instillation site irritation | General disorders | Lifitegrast | 65 | 357 | 68 |
| other | Instillation site reaction | General disorders | Placebo | 19 | 354 | 21 |
| other | Instillation site reaction | General disorders | Lifitegrast | 45 | 357 | 51 |
| other | Dysgeusia | Nervous system disorders | Placebo | 1 | 354 | 1 |
| other | Dysgeusia | Nervous system disorders | Lifitegrast | 46 | 357 | 46 |
| serious | Pneumonia | Infections and infestations | Placebo | 0 | 354 | 0 |
| serious | Pneumonia | Infections and infestations | Lifitegrast | 1 | 357 | 1 |
| serious | Periprosthetic fracture | Injury, poisoning and procedural complications | Placebo | 1 | 354 | 1 |
| serious | Periprosthetic fracture | Injury, poisoning and procedural complications | Lifitegrast | 0 | 357 | 0 |
| serious | Lower limb fracture | Musculoskeletal and connective tissue disorders | Placebo | 1 | 354 | 1 |
| serious | Lower limb fracture | Musculoskeletal and connective tissue disorders | Lifitegrast | 0 | 357 | 0 |
| serious | Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 354 | 1 |
| serious | Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Lifitegrast | 0 | 357 | 0 |
| serious | Cerebrovascular accident | Nervous system disorders | Placebo | 0 | 354 | 0 |
| serious | Cerebrovascular accident | Nervous system disorders | Lifitegrast | 1 | 357 | 1 |
| serious | Transient ischaemic attack | Nervous system disorders | Placebo | 0 | 354 | 0 |
| serious | Transient ischaemic attack | Nervous system disorders | Lifitegrast | 1 | 357 | 1 |
| serious | Lung neoplasm malignant | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 354 | 0 |
| serious | Lung neoplasm malignant | Respiratory, thoracic and mediastinal disorders | Lifitegrast | 1 | 357 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02284516/events